Cargando…

Antigen-armed antibodies against B-cell malignancies

Detalles Bibliográficos
Autores principales:	Ilecka, Marta, van Zyl, Dwain G., Delecluse, Henri-Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235021/ https://www.ncbi.nlm.nih.gov/pubmed/30479687 http://dx.doi.org/10.18632/oncotarget.26276

Ejemplares similares

Progress in EBV Vaccines
por: van Zyl, Dwain G., et al.
Publicado: (2019)

Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice
por: van Zyl, Dwain G., et al.
Publicado: (2018)

Epstein-Barr virus infectious particles initiate B cell transformation and modulate cytokine response
por: Baccianti, Francesco, et al.
Publicado: (2023)

Advances and Perspectives in the Treatment of B-Cell Malignancies
por: Cuenca, Marta, et al.
Publicado: (2021)

Immunoinformatic Analysis Reveals Antigenic Heterogeneity of Epstein-Barr Virus Is Immune-Driven
por: Cirac, Ana, et al.
Publicado: (2021)

Quantitative pharmacology in antibody-drug conjugate development: armed antibodies or targeted small molecules?
por: Nessler, Ian, et al.
Publicado: (2018)

Reaching Un-Drugable Intracellular Targets with the Long Arm of Antibodies
por: Scheinberg, David A., et al.
Publicado: (2013)

The expression of a viral microRNA is regulated by clustering to allow optimal B cell transformation
por: Haar, Janina, et al.
Publicado: (2016)

Importance of human leukocyte antigen antibodies and leukocyte antigen/killer-cell immunoglobulin-like receptor genes in liver transplantation
por: Muro, Manuel, et al.
Publicado: (2023)

The Role of B-Cells and Antibodies against Candida Vaccine Antigens in Invasive Candidiasis
por: Shukla, Manisha, et al.
Publicado: (2021)

Human Leukocyte antigen-G (HLA-G) and gastrointestinal malignancy
por: Nazemalhosseini-Mojarad, Ehsan, et al.
Publicado: (2014)

New Insights into Malignant B-Cell Disorders
por: Kyrtsonis, Marie-Christine, et al.
Publicado: (2015)

Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies
por: Ying, Zhitao, et al.
Publicado: (2021)

Epstein-Barr virus genetics: talking about the BAC generation
por: Feederle, Regina, et al.
Publicado: (2010)

A and B Antigens of Normal and Malignant Cells
por: Kay, H. E. M.
Publicado: (1957)

Translational profiling of B cells infected with the Epstein-Barr virus reveals 5′ leader ribosome recruitment through upstream open reading frames
por: Bencun, Maja, et al.
Publicado: (2018)

Biological Insights into Myeloma and Other B Cell Malignancies
por: Fulciniti, Mariateresa, et al.
Publicado: (2016)

Farewell to Arms
por: Walker, Richard F
Publicado: (2021)

Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies
por: Walti, Carla S., et al.
Publicado: (2021)

Bispecific antibodies with Fab-arms featuring exchanged antigen-binding constant domains
por: Benedetti, Filippo, et al.
Publicado: (2021)

Molecular Recognition and Advances in Antibody Design and Antigenic Peptide Targeting
por: Houen, Gunnar, et al.
Publicado: (2020)

Advances in Antibody Design and Antigenic Peptide Targeting 2.0
por: Trier, Nicole Hartwig, et al.
Publicado: (2023)

Kidins220/ARMS binds to the B cell antigen receptor and regulates B cell development and activation
por: Fiala, Gina J., et al.
Publicado: (2015)

The Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B Cells
por: Lin, Xiaochen, et al.
Publicado: (2015)

PU.1 is a tumor suppressor for B cell malignancies
por: Okuno, Yutaka, et al.
Publicado: (2012)

Ibrutinib repurposing: from B-cell malignancies to solid tumors
por: Massó-Vallés, Daniel, et al.
Publicado: (2016)

Chimeric Antigen Receptor Therapy for B-cell Malignancies
por: Porter, David L, et al.
Publicado: (2011)

A Farewell to Arms
por: van der Wall, E. E.
Publicado: (2016)

Welcome with Open arms!
por: Simonds, Anita K.
Publicado: (2015)

The viral arms race
Publicado: (2021)

Vingt études d'aprés R. Kreutzer, adaptées au xylophone. Twenty studies after R. Kreutzer, arranged for xylophone
por: Delécluse, Jacques
Publicado: (1964)

Metagenomic analysis of primary colorectal carcinomas and their metastases identifies potential microbial risk factors
por: Marongiu, Luigi, et al.
Publicado: (2021)

Ignorance is never bliss when it comes to patient care
por: van Zyl-Smit, Richard
Publicado: (2018)

COVID-19 brought out the best and worst of us
por: van Zyl-Smit, Richard
Publicado: (2022)

Critical care for patients with potentially fatal haematological disorders
por: van Zyl-Smit, Richard
Publicado: (2023)

Editorial on “Cell Therapy, Bispecific Antibodies and Other Immunotherapies against Cancer”
por: Golubovskaya, Vita
Publicado: (2023)

Novel human recombinant antibodies against Mycobacterium tuberculosis antigen 85B
por: Fuchs, Manon, et al.
Publicado: (2014)

Adjuvants and Antigen-Delivery Systems for Subunit Vaccines against Tuberculosis
por: Mustafa, Abu Salim
Publicado: (2021)

Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens
Publicado: (1975)

Tuning B cell responsiveness by antigen receptor isotype
por: Jumaa, Hassan
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oe0ab68tqkjnmlnbmtqe6e6vbn